Adjuvant chemotherapy is associated with improved survival in patients with nodal metastases after neoadjuvant therapy and esophagectomy.

Drake, Justin; Tauer, Kurt; Portnoy, David; Weksler, Benny

Drake, Justin; Tauer, Kurt; Portnoy, David; Weksler, Benny.

Afiliación

Drake J; Division of Thoracic Surgery, Department of Surgery, University of Tennessee Health Science Center, and West Cancer Center, Memphis, TN, USA.
Tauer K; Division of Medical Oncology, Department of Medicine, University of Tennessee Health Science Center, and West Cancer Center, Memphis, TN, USA.
Portnoy D; Division of Medical Oncology, Department of Medicine, University of Tennessee Health Science Center, and West Cancer Center, Memphis, TN, USA.
Weksler B; Division of Thoracic Surgery, Allegheny General Hospital, Pittsburgh, PA, USA.

J Thorac Dis ; 11(6): 2546-2554, 2019 Jun.

Article en En | MEDLINE | ID: mdl-31372291

Palabras clave

Esophageal adenocarcinoma; adjuvant chemotherapy; esophagectomy; propensity matching

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Thorac Dis Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google